Seeking Alpha

Onyx Pharmaceuticals Inc. (ONXX)

()

News & PR
Market Currents

Buzz
Twitter: ONXX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

13 Biotechs to Watch for at Hematology Conference

Nov 30 • Michael Becker • Comment!
11 'Babies with Bathwater' and 20 'Dogs with Fleas' Stocks for the Week

Nov 16 • J Clinton Hill • 3 Comments
Wall Street Breakfast: Must-Know News

Nov 4 • SA Editor Eli Hoffmann • 14 Comments
Onyx Pharmaceuticals: Could Acquiring Proteolix Be the Deal of the Year?

Oct 22 • Prohost Biotech • 1 Comment
Biotech Companies Turn to Capital Markets

Oct 18 • The Burrill Report • Comment!
Onyx / Proteolix: Checking the Synergy of the Acquisition

Oct 13 • Douglas Cress • Comment!
Onyx to Acquire Cancer Drugmaker Proeolix

Oct 13 • Zacks.com • Comment!
Weekly Street Sentiment: Sell Side Loves Everything and Everybody

Oct 13 • First Coverage • 3 Comments
Bayer / Onyx Cancer Drug: Possible Additional Indication Looks Promising

Sep 27 • Zacks.com • Comment!
Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer

Sep 23 • Prohost Biotech • 1 Comment
Onyx Pharmaceuticals: Is Nexavar the Next Avastin?

Sep 22 • Raymond Chung • 5 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned

Aug 13 • Raymond Chung • 2 Comments
Tuesday's Options Recap

Aug 11 • Frederic Ruffy • Comment!
Onyx Signaling Appetite for Deals

Aug 11 • EP Vantage • 3 Comments
Who Will Buy Spectrum Pharmacueticals?

Aug 6 • Mark Cifra • 2 Comments
Too Late to Board the Biotech Bandwagon?

Jul 28 • Sam Subramanian • 5 Comments
VC Financings Boost Interest in Biotech

Jul 24 • The Burrill Report • Comment!
FDA Calendar Updates: Schering-Plough, Hemispherx, Bovie Medical

Jul 23 • Mike Havrilla • Comment!
Pharmaceutical Dollar Rationing by Results

Jul 1 • Michael Steinberg • 14 Comments
Keryx: Another Beneficiary of the ASCO Effect

Jun 3 • Michael Becker • 5 Comments
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships

Jun 2 • Zacks.com • 15 Comments
Big Pharma's Pheeding Phrenzy

May 28 • Mike Huckman • Comment!
Pequot Capital Closes: Expect Downward Pressure on Top Holdings

May 28 • Todd Walker • 4 Comments
Friday's Options Recap

May 8 • Frederic Ruffy • 1 Comment
Pequot Capital: Yet Another Hedge Fund Buying Gold

Mar 27 • Market Folly • 2 Comments
Arena's Financing Deal with Azimuth Is a Healthy Move

Mar 25 • Mark Cifra • 10 Comments
Tudor Investment Takes New Positions in Financials, Among Others

Mar 17 • Market Folly • 3 Comments
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
China Biopharma Undergoes Systemic Changes

Jan 25 • ChinaBio Today • Comment!
China Biotech Gets Off to a Slow Start for 2009

Jan 11 • ChinaBio Today • Comment!
Fast Money Recap - Bullish on Biotech (1/5/09)

Jan 6 • SA Editor Miriam Metzinger • Comment!
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008

Dec 30, 2008 • Market Folly • Comment!
What Are Some of the Best Hedge Fund Managers Doing?

Nov 19, 2008 • Keith Robison • 11 Comments
Onyx's $320M Bet on BTG's Anticancer Compound

Nov 10, 2008 • Eben Tessari • Comment!
Even Fatter Yields for Pfizer; M&A Targets in the Sector

Oct 17, 2008 • Mike Havrilla • 3 Comments
U.K. Limits 'Quality of Life' Meds to £30,000 a Year

Oct 12, 2008 • Michael Steinberg • 3 Comments
41 Stocks Returning 10% or More Last Week

Aug 17, 2008 • TraderMark • 8 Comments
5 Potential Buyout Targets in Biotech - Barron's

Aug 17, 2008 • SA Editor Rachael Granby • 9 Comments
A Biotech Bloom in July

Jul 28, 2008 • Option Dragon • 10 Comments

Onyx Pharmaceuticals Inc. (ONXX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers